Results 211 to 220 of about 14,911 (253)

[Subjectivities promoted by food and nutrition policies: The case of Comuna 1 Popular in Medellín, Colombia]. [PDF]

Salud Colect
Giraldo-López PA, Mancilla-López L, Muñoz-Duque LA.   +2 more
europepmc   +1 more source

Non‐Metastatic Squamous Cell Carcinoma of the Oropharynx: Primary Surgery or (Chemo)radiotherapy?

Head &Neck, EarlyView.
ABSTRACT Background In patients with locally advanced, non‐metastatic oropharyngeal squamous cell carcinoma (OPSCC), surgery‐based and nonsurgical treatment approaches have not been adequately compared in randomized Phase III clinical trials. Current clinical guidelines recommend various surgical and nonsurgical strategies across disease stages for ...
Primož Strojan, Avraham Eisbruch, June Corry, Sandra Nuyts, Pim de Graaf, Luiz P. Kowalski, Jonathan J. Beitler, Sweet Ping Ng, William M. Mendenhall, M. P. Sreeram, Karthik N. Rao, Anna Luíza Damaceno Araújo, Alfio Ferlito   +12 more
wiley   +1 more source

Pregnancy in patients with chronic kidney disease undergoing dialysis. [PDF]

J Bras Nefrol
Gorayeb-Polacchini FS, Moura AF, Luders C, Moura Neto JA, Leme JEG, Silva DRD.   +5 more
europepmc   +1 more source

Integrating Immunotherapy Into Head and Neck Surgery: Bridging Tumor Biology to Perioperative Decision‐Making, a Review

Head &Neck, EarlyView.
ABSTRACT Objective To provide a comprehensive review of the biological rationale, clinical evidence, and practical perioperative management of immunotherapy for the head and neck surgeon. Summary Background Data Standard treatment for resectable head and neck squamous cell carcinoma (HNSCC) has reached a survival plateau, with over 50% of patients ...
Nicholas Brian Shannon, Bruce Ashford
wiley   +1 more source

Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia. [PDF]

Colomb Med (Cali)
Benjumea-Bedoya D, Robledo-Restrepo JA, Arbelaez-Montoya MP, Estupiñán-Bohorquez AF, Sabella-Jimenez VS, Restrepo-Gouzy AV, Beltran-Arroyave CP, Bedoya-Giraldo J, Niederbacher-Velasquez J, Hurtado-Palacios IC, Cadavid-Álvarez LM, Vanegas-Rojas DE, Murillo Tenorio M, Paniagua-Saldarriaga L, Arteaga-Noriega AV, Sierra JM, Vélez CM, Botero-Garcés JH, Montes-Zuluaga FN, Villegas-Arbelaez E, Castaño-Osorio D, Andrade-Agudelo VH, Pedraza-Moreno LM, Cruz-Martínez OA, Llerena-Polo C, Gómez AJ, Gil-Artunduaga M, Cataño ML, Florez ID.   +28 more
europepmc   +1 more source

Vaccination Coverage Against Coronavirus Disease 2019 (COVID-19) in Brazil's Indigenous Population. [PDF]

J Med Virol
Sansone NMS, Costa PT, Mello LS, Marques LFA, Santos VSD, Marson FAL.   +5 more
europepmc   +1 more source

Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average‐Risk Populations, and Future Directions

International Journal of Cancer, EarlyView.
ABSTRACT Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome and is characterized by an accelerated adenoma‐carcinoma sequence, a relatively higher prevalence of flat and subtle CRC precursor lesions, and exceptionally high adenoma miss rates despite intensive colonoscopy surveillance.
Robert Hüneburg, Querijn N. E. van Bokhorst, Evelien Dekker, Jacob Nattermann   +3 more
wiley   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source